Masayuki Inoo

529 total citations
13 papers, 219 citations indexed

About

Masayuki Inoo is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Masayuki Inoo has authored 13 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 6 papers in Pathology and Forensic Medicine and 5 papers in Genetics. Recurrent topics in Masayuki Inoo's work include Rheumatoid Arthritis Research and Therapies (7 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Masayuki Inoo is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Masayuki Inoo collaborates with scholars based in Japan and United Kingdom. Masayuki Inoo's co-authors include Koichi Amano, Masayuki Miyata, Nobuyuki Miyasaka, Yoshiya Tanaka, Shintaro Hirata, Yuko Kaneko, Yohko Murakawa, Tsutomu Takeuchi, Hisashi Yamanaka and Kazuhiko Yamamoto and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Care & Research and Modern Rheumatology.

In The Last Decade

Masayuki Inoo

11 papers receiving 215 citations

Peers

Countries citing papers authored by Masayuki Inoo

Since Specialization

Citations

This map shows the geographic impact of Masayuki Inoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Inoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Inoo more than expected).

Fields of papers citing papers by Masayuki Inoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Inoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Inoo. The network helps show where Masayuki Inoo may publish in the future.

Co-authorship network of co-authors of Masayuki Inoo

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Inoo. A scholar is included among the top collaborators of Masayuki Inoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Inoo. Masayuki Inoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	FRI0099 PREDICTIVE FACTORS FOR REMISSION ACHIEVEMENT BY TOCILIZUMAB MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER INADEQUATE RESPONSE TO METHOTREXATE: A POST HOC ANALYSIS OF THE SURPRISE STUDY 2019 ·Annals of the Rheumatic Diseases ·Masaru Kato, Yuko Kaneko, Yoshiya Tanaka, Masayuki Inoo, (unknown), Koichi Amano, Masayuki Miyata, Yohko Murakawa, Hidekata Yasuoka, Shintaro Hirata, Hayato Nagasawa, Eiichi Tanaka, Nobuyuki Miyasaka, Hisashi Yamanaka, Kazuhiko Yamamoto, Isao Yokota, Tatsuya Atsumi, Tsutomu Takeuchi	1
2	Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study 2019 ·Modern Rheumatology ·Masaru Kato, Yuko Kaneko, Yoshiya Tanaka, Masayuki Inoo, (unknown), Koichi Amano, Masayuki Miyata, Yohko Murakawa, Hidekata Yasuoka, Shintaro Hirata, Hayato Nagasawa, Eiichi Tanaka, Nobuyuki Miyasaka, Hisashi Yamanaka, Kazuhiko Yamamoto, Isao Yokota, Tatsuya Atsumi, Tsutomu Takeuchi	3
3	Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study) 2018 ·Annals of the Rheumatic Diseases ·Yuko Kaneko, Masaru Kato, Yoshiya Tanaka, Masayuki Inoo, (unknown), Koichi Amano, Masayuki Miyata, Yohko Murakawa, (unknown), Shintaro Hirata, Eiichi Tanaka, Nobuyuki Miyasaka, Hisashi Yamanaka, Kazuhiko Yamamoto, Tsutomu Takeuchi	38
4	THU0170 Outcomes of the rapid dose escalation of methotrexate in japanese patients with early rheumatoid arthritis; results from a randomized controlled trial 2017 ·Annals of the Rheumatic Diseases ·(unknown), Ryoko Sakai, (unknown), Koichi Amano, Ryusuke Yoshimi, Masayuki Inoo, Hiroaki Dobashi, Takahiko Sugihara, Takayuki Hidaka, Hitoshi Kohsaka, N. Miyasaka, Masayoshi Harigai	1
5	THU0209 Lymphocyte subsets in biopsy specimen are associated with spontaneous regression of lymphoproliferative disorders in rheumatoid arthritis patients treated with methotrexate 2017 ·Annals of the Rheumatic Diseases ·Tomohiro Kameda, (unknown), Masayuki Inoo, (unknown), Noriyuki Kurata, S. Nakashima, Hiromi Shimada, Hiroki Ozaki, (unknown), Akihiro Kondo, Norimitsu Kadowaki, Hiroaki Dobashi	0
6	Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study) 2016 ·Annals of the Rheumatic Diseases ·Yuko Kaneko, Tatsuya Atsumi, Yoshiya Tanaka, Masayuki Inoo, (unknown), Koichi Amano, Masayuki Miyata, Yohko Murakawa, Hidekata Yasuoka, Shintaro Hirata, Hayato Nagasawa, Eiichi Tanaka, Nobuyuki Miyasaka, Hisashi Yamanaka, Kazuhiko Yamamoto, Tsutomu Takeuchi	80
7	Changes in foot function, disease activity, and disability after forefoot resection arthroplasty in patients with rheumatoid arthritis 2016 ·The Journal of Medical Investigation ·Fusakazu Sawachika, Hirokazu Uemura, Sakurako Katsuura‐Kamano, Miwa Yamaguchi, (unknown), (unknown), (unknown), Masayuki Inoo, (unknown), Noriyuki Kurata, Kokichi Arisawa	3
8	AB0294 Lymphocyte Recovery after Methotrexate Discontinuation Relate To Spontaneous Regression of Mtx-Lpd in Ra Patients 2016 ·Annals of the Rheumatic Diseases ·Tomohiro Kameda, Hiroaki Dobashi, Masayuki Inoo, (unknown), Noriyuki Kurata, (unknown), S. Nakashima, Hiromi Shimada, Hiroki Ozaki, (unknown), Norimitsu Kadowaki	1
9	Association of Higher Methotrexate Dose With Lymphoproliferative Disease Onset in Rheumatoid Arthritis Patients 2014 ·Arthritis Care & Research ·Tomohiro Kameda, Hiroaki Dobashi, Nobuyuki Miyatake, Masayuki Inoo, (unknown), Noriyuki Kurata, (unknown), (unknown), (unknown), (unknown), (unknown), S. Nakashima, Hiromi Shimada, (unknown), Reiji Haba, (unknown), Hiroaki Onishi, Osamu Imataki, Takuya Matsunaga	65
10	FRI0207 A phase I/II clinical trial of intra-articular administration of ARG098, an anti-FAS IGM monoclonal antibody, in knee joint synovitis of japanese patients with rheumatoid arthritis 2012 ·Annals of the Rheumatic Diseases ·Tsukasa Matsubara, (unknown), Junji Chiba, (unknown), H. Inoue, (unknown), Hiroki Wakabayashi, Atsushi Kaneko, K. Sugimoto, (unknown), (unknown), Yoshinari Takasaki, Naoto Tamura, Michihiro Ogasawara, Masayuki Inoo, (unknown), Shinichi Kawai, Ryuji Nohara	2
11	A case of femoral nerve palsy caused by iliopectineal bursitis associated with rheumatoid arthritis 2004 ·Modern Rheumatology ·Satoshi Mori, (unknown), Satoshi Komatsubara, (unknown), (unknown), Masayuki Inoo, Noriyuki Kurata, Hiromichi Norimatsu	13
12	A case of femoral nerve palsy caused by iliopectineal bursitis associated with rheumatoid arthritis 2004 ·Modern Rheumatology ·Satoshi Mori, (unknown), Satoshi Komatsubara, (unknown), (unknown), Masayuki Inoo, Noriyuki Kurata, Hiromichi Norimatsu	12
13	Etoposide and ifosfamide for MP(melphalan and prednisolone)-and VAD(vincristine, adriamycin and dexamethasone)-resistant plasma cell myeloma:A case report. 1990 ·Japanese Journal of Medicine ·Kazuma Ikeda, Nobuyuki Abe, Akira Morioka, Masayuki Inoo, Masami Nagai, (unknown), S Irino	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact